We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Horizon Discovery Group Plc | HZD | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 184.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 184.50 | 184.50 |
| Top Posts |
|---|
Posted at 25/11/2020 17:00 by bouleversee Yes, I understand that. I meant I was dithering over whether to sell them now rather than wait for the deal to go through at a lower price than I could get now, assuming it does go through. I see the share price was 200 first thing this a.m., now 191.Investigate issues these reports daily; this is today's, which shows a larger number than yesterday's. What exactly does this mean? That HZD have issued more shares or they have bought more? If they had enough unconditional support to secure the vote, surely they wouldn't need to do the latter, would they? Why is anyone they prepared to pay more now than they will get (or have to pay out) when the deal completes? I'd expect the share price to be lower than the t/o price if it's a done deal. Is there another bidder in the wings or is there a chance that the deal won't go through? Have they already got sufficient committed acceptances, in which case why does the share price keep going up? Or is it shorters having to buy back at a high price? All very confusing. Edit: I left out the report: "In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Horizon confirms that, on 25 November 2020 (the date of this announcement), it has 158,310,476 ordinary shares of £0.01 each in issue and admitted to trading on AIM. The International Securities Identification Number ("ISIN") for the Company's ordinary shares is GB00BK8FL363." |
Posted at 20/11/2020 11:43 by bouleversee I'm still holding and debating what to do. I don't know whatto make of s.pmovements. Numis seems to be trading in HZD but who are they selling to? |
Posted at 10/11/2020 16:03 by thewheeliedealer Hi all,My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes HZD and how we deal with Takeover situations. We also chatted about loads of other Stocks and Ideas for research with a particular slant on potential Takeover Targets, and the outlook for Markets and as usual a fair bit of educational stuff with regards to Investing. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 35) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer |
Posted at 02/11/2020 15:21 by rambutan2 So, only Inclusive has thrown its hat (20%) in with the offer so far. And they were in need of an exit due to the changes in remit etc. If HZD really does own IP etc of strategic value, then there is a good chance someone else will counter the offer imho. |
Posted at 02/11/2020 09:46 by halfpenny HZD have exceeded expectations as we have great news. MERRY XMAS EVERYONE... especially to those who believed in HZD. IXI is another opportunity with fantastic solutions and products. |
Posted at 18/10/2020 09:19 by the stigologist Video explaining Crispr for AIM investors#HZD #MXCT #C4XD |
Posted at 17/8/2020 16:37 by halfpenny HZD are now ready to move forward with many Deals in their Pipeline. News flow will come thick and fast and £1.30? will be Sooner than some think. Get ready as HZD can move up very quickly.... |
Posted at 17/8/2020 13:01 by halfpenny HZD Q3 R&D project driving benefits. HZD Technology driving business customers with UP Front Payments and Royalty. Edit T Cell features changes cell to become a drug. 20/3O million within next 5 years. News update expected this year. Expect return to normality H2. Cash being managed well. EBITDA should improve H2. Staff turnover 15%. IT costs for new website improves services and quality ISO210007 certified this year. Nasdaq listing being worked on. Operating cash flow still positive.Outlook positive and way of working from home working well. Customers relationships improving to a higher level. Outsourcing with sticky services growing H2. Developing screening market and bio production. Drivers remain strong and growing revenue in H2. Q&A Assumption return to growth H2. Driver Academic customers. Customers returning back to work driving demand. RNAI for Covid research online growing. Bio production a challenge and crystal libraries. Outsourcing And Strong Partnership is benefiting HZD. Expecting to outgrow target market overall. Diagnostics and cell line Engineering should grow rapidly and enquiries increasing rapidly. Enjoy HZD price increases for the rest of 2020 and into 2021. My short term Target £1.30 plus plus plus. Future is BRIGHT.. |
Posted at 17/8/2020 11:58 by halfpenny HZD get ready for the HZD conference call with news flow....starts 12 noon |
Posted at 14/8/2020 19:46 by halfpenny HZD had a strong finish today. Monday should be fantastic news with HZD being Hot Hot Hot with a £1.30 target...News flow will be great and surprisingly positive for HZD. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
